BUSINESS BRIEFS: New residency clinic, new broker associates, global clinical trial

AdventHealth Ocala Family Medicine Program physicians and the inaugural class of Family Medicine Resident Physicians. [Photo courtesy AdventHealth]

Residency clinic opens

AdventHealth Ocala on Aug. 14 cut the ribbon on its new Family Medicine Residency Practice clinic at 221 SW 11^th St., Ocala.

The clinic, which features 20 exams rooms, two procedure rooms, a lab, a classroom and 15 offices, will serve as a training ground for the hospital’s inaugural class of graduate medical residents who will work alongside experienced physicians. Graduate medical education is the final phase of medical training that equips physicians to become independent physicians in their specialty, the news release noted.

The hospital’s Clinic First residency curriculum emphasizes family medicine outpatient practice as the primary site for clinical training. Residents will work closely with attending physicians across all specialties and immerse themselves in AdventHealth’s whole-person care model.

New broker associates named

Showcase Properties of Central Florida has announced that agents Dawn Mahler and Tina Halsteter have been named broker associates after completing certification exams in July.

Dawn Mahler

Mahler was awarded Rookie of the Year by OMCAR in 2021 and since 2022 has been recognized with the Outstanding Achiever Award each year for selling over $3,000,000 in property volume. She is a volunteer at VFW Post 4209.

Tina Halsteter

Halsteter also was named Rookie of the Year in 2021 and each consecutive year since has been awarded two Outstanding Achiever Awards and a Top Producer Award. She serves on the board of directors for the Marion Therapeutic Riding Association and has been involved in the Equine Alliance Committee.

Hospital joins global clinical trial

HCA Florida Ocala Hospital will participate in a clinical trial to assess the safety and effectiveness of a next-generation heart valve implant. The study launched on Aug. 12 as the first procedure was performed at HCA Florida Ocala Hospital. Its outcomes could help redefine treatment standards for aortic stenosis, according to the news release.

The clinical trial, sponsored by Abbott, will evaluate the safety and effectiveness of the Navitor Transcatheter Aortic Valve Implantation system in patients with severe aortic stenosis who are at low or intermediate surgical risk. If successful, the trial could lead to expanded approval by the U.S Food and Drug Administration for use of the valve in lower-risk patients, the release noted.

Members of the team that performed the first implant surgery to launch the clinical trial. [Photo courtesy HCA Florida]